GlassScriptPhysician profile
Leah Michelle Lin
NPI 1871763177
$1,459.92
in general payments reported to CMS, 2019-2025
16 companies · $805 in 2025
The $805 reported for 2025 was more than what 94% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $122 · 2023: $159 · 2024: $373 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,337.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $674.85 | 2023-2025 | Aptima, Novasure, Fluent Fluid Management System |
| Mayne Pharma Commercial LLC | $301.55 | 2024-2025 | |
| Viiv Healthcare Company | $122.06 | 2022 | |
| Astellas Pharma US INC | $90.06 | 2024-2025 | Veozah |
| Shield Therapeutics INC | $40.96 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.17 | 2025 | |
| Sumitomo Pharma America, INC. | $30.71 | 2024-2025 | Myfembree |
| Sage Therapeutics, LLC | $30.19 | 2025 | Zurzuvae |
| Coloplast Corp | $22.83 | 2024 | |
| Gynesonics, INC. | $20.88 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Amphastar Pharmaceuticals, INC. | $18.63 | 2025 | |
| Coopersurgical, INC. | $17.98 | 2024 | Paragard T 380a |
| Supernus Pharmaceuticals, INC. | $16.46 | 2025 | Qelbree |
| Exeltis, USA INC. | $13.89 | 2024 | Slynd |
| Exact Sciences Corporation | $13.69 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $10.01 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.